October 2025

A listing of the individual articles included in the Jurisdiction F Medicare A News bulletin dated October 2025 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
2025 Q3 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective July 1, 2025
ACM Questions and Answers - July 17, 2025
Acute Kidney Injury Renal Dialysis Billing: Additional Revenue Codes CR14159
Alert: Medicare Fraud Scheme Involving Phishing Fax Requests
Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) Final LCD - Effective October 26, 2025
August is Suicide Prevention Awareness Month
Billing and Coding Investigational Device Exemptions (IDE) - IDE Documentation Requirements for Studies with an FDA Approval dated January 01, 2015, or later (A54917) - R8 - Effective October 1, 2015
Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices (A59658) - R2 - September 30, 2024
Billing and Coding: BDX-XL2 (A57357) - R5 - Effective April 28, 2022
Billing and Coding: Billing Limitations for Pharmacies (A56124) Retirement - Effective September 18, 2025
Billing and Coding: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (A57949) - R6 - Effective January 1, 2025
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R21 - Effective July 1, 2025
Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57864) - R8 - Effective November 17, 2024
Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) (A55712) - R7 - Effective June 1, 2023
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57055) - R6 - Effective October 1, 2025
Billing and Coding: MolDX: Breast Cancer Index (BCI) Gene Expression Test (A57774) - R4 - Effective October 9, 2021
Billing and Coding: MolDX: FDA-Approved KRAS Tests (A54500) - R9 - Effective July 14, 2022
Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (A59870) - R1 - Effective August 17, 2025
Billing and Coding: MolDX: Germline testing for use of PARP inhibitors (A55295) - R12 - Effective October 1, 2025
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681) - R9 - Effective October 1, 2025
Billing and Coding: MolDX: MammaPrint (A54447) - R9 - Effective January 1, 2022
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R11 - Effective July 1, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R12 - Effective July 31, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R13 - Effective October 1, 2025
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R24 - Effective August 14, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R26 - Effective July 1, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R27 - Effective October 1, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R29 - Effective October 1, 2025
Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (A59874) - R1 - Effective August 17, 2025
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A58170) - R11 - Effective July 24, 2025
Billing and Coding: MolDX: Oncotype DX Colon Cancer (A54486) - R4 - Effective November 1, 2019
Billing and Coding: MolDX: Pharmacogenomics Testing (A57385) - R16 - Effective July 1, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58975) - R10 - Effective July 1, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58975) - R9 - Effective July 1, 2025
Billing and Coding: MolDX: Prometheus IBD sgi Diagnostic Policy (A57517) - R4 - Effective October 20, 2022
Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (A57236) - R5 - Effective January 1, 2021
Billing and Coding: MolDX: Proteomics Testing (A59642) - R10 - Effective August 14, 2025
Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers - Coding and Billing (A54931) - R11 - Effective October 1, 2023
Billing the Laboratory Specimen Collection Travel Allowance to the 10th of a Mile CR14130
Bypassing CWF Edits on Inpatient Medicare Part B Ancillary 12X Claims: Effective Date Change CR14185
CAH Claims Receiving Reason Code 31006 or 31007 in Error - Resolved 09/09/25 Alert
CERT Awareness Month: 2025 CERT Documentation Deadline
CERT Awareness Month: Steps to Take if You Get a Cert Documentation Request
CERT Awareness Month: Verify Your Medical Records Correspondence Address
CERT Awareness Month: We Appreciate Your Efforts
CLFS Subject to Reasonable Charge Payment: October 2025 Update CR14211
CMS 2552-10 Transition to Automated Tentative Settlements
CMS Extends G0511 Billing for Federally Qualified Health Centers (FQHCs) and Rural Health Centers (RHCs) until September 30, 2025
Connecting Beneficiaries and Suicide Prevention Resources
CORRECTED Billing and Coding: MolDX: Prometheus IBD sgi Diagnostic Policy (A57517) - R4 - Effective October 20, 2022
— 50 Items per Page
Showing 1 - 50 of 134 results.